Proximare, a leading management consulting firm that specializes in pharmaceutical and related industries carried out a comprehensive study of India's clinical research industry by analyzing key drivers, regulatory environment and all key CROs offering phase I, phase II, phase III, phase IV, BA/BE studies and related services. Awards are an outcome of this comprehensive and neutral study.
Princeton, USA (PRWEB) September 6, 2005 -- Proximare Inc., a leading
management consulting firm that specializes in the pharmaceutical, biotech and
related industries announced eleven finalists in three categories for
Proximare’s Best Indian CRO of 2005 Awards. The awards will be presented at the
Drug Discovery to Clinical Trials conference in Mumbai on October 5th at 12 PM
at the Renaissance Mumbai Hotel & Convention Centre.
The finalists in clinical research category (CROs providing Phase I to Phase IV services) are: Asian Clinical Trials, iGate Clinical Research, Neeman Medical International and Siro Clinpharm.
Finalists in CROs providing BA/BE Studies are: Accutest, Lambda, Lotus and Vimta.
Finalists in the Emerging CROs or companies to watch are: Ace Biomed, GVKBio and Manipal Accunova.
The selection of finalists is an outcome of a comprehensive and unbiased analysis of India’s clinical research industry, carried out by Proximare team. This has been the most comprehensive analysis of India’s clinical research industry to date, which covers understanding key drivers for outsourcing clinical trials to India to analysis of the clinical research industry in India. More than sixty CROs were identified and comprehensive due diligence was carried out. The report will be read by decision makers at pharmaceutical, biotech, clinical research and investment community around the world.
Mr. Nailesh A. Bhatt, managing director of Proximare said, “We are pleased to announce the finalists in this category. These companies are pioneers and have created significant and impressive infrastructure to provide valuable services to the global clinical research industry. Indian clinical research industry is estimated to be around $100 million and is expected to grow significantly over the next few years. We are proud of our report and look forward to the awards ceremony in Mumbai in early October.”
"Key benefits of this report are that they are comprehensive, neutral and allows the reader to understand the overall clinical research industry landscape in India as well as specifics about every CRO," Bhatt added.
Small and large pharmaceutical and biotech companies are aggressively leveraging India's value proposition in clinical research, including Pfizer, GSK, AstraZeneca, Lilly, Bausch & Lomb and many other companies. "The main goal of this report is to provide the most comprehensive and unbiased report of the Indian clinical research industry to the global decision makers of clinical research outsourcing," Bhatt added.
About Proximare Inc.:
Proximare, with offices in Princeton, USA and Mumbai, India, is one of the leading management consulting firms that develops and implements growth strategies for pharmaceutical, biotech and related industries. To date, Proximare has developed more than $200 million of outsourcing and off-shoring strategies for drug discovery, clinical research, manufacturing of intermediates, APIs and finished dosages. www.proximare.com
# # #
Source : http://www.prweb.com/releases/2005/9/prweb280604.htm